Tomas Jelinek

35PUBLICATIONS
233CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunityMedical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Jun 12, 2026
Outcomes of CAR-T Cell Therapy and Bispecific Antibodies as Single-Modality and Sequential Strategies in Relapsed/Refractory Multiple Myeloma.

|Feb 27, 2026
Isatuximab, bortezomib, lenalidomide, and dexamethasone for multiple myeloma: dynamics of MRD negativity in the IMROZ study.

Robert Z Orlowski, Meletios A Dimopoulos, Xavier Leleu

|Jan 29, 2026
Immune biomarkers of increased infection risk in multiple myeloma.

Aintzane Zabaleta, Luis-Esteban Tamariz-Amador, Ioannis V Kostopoulos

|Nov 14, 2025
Composition and Functional State of T and NK Cells in the Extramedullary Myeloma Tumor Microenvironment.

Anjana Anilkumar Sithara, Veronika Kapustova, David Zihala

|Sep 24, 2025
OMIP-117: 40-Parameter/37-Color Spectral Cytometry Panel for Robust Immunoprofiling of Human Lymphoid Subsets in Cancer Patients.

Ondrej Venglar, Eva Radova, Lucie Broskevicova

|Aug 05, 2025
Modification of belantamab mafodotin dosing to balance efficacy and tolerability in the DREAMM-7 and DREAMM-8 trials.

María-Victoria Mateos, Suzanne Trudel, Hang Quach

Pageof 6

Frequent Collaborators

14 joint publications

Roman Hajek

8 joint publications

Tereza Popkova

7 joint publications

Michal Simicek

6 joint publications

Jiri Minarik